Immunitybio (IBRX) had the highest return between October 1, 2023 and November 30, 2023 by a mid-cap US stock, returning 116.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 10/1/2023 - 11/30/2023 | 116.47% |
Gap (GAP) | 10/1/2023 - 11/30/2023 | 90.93% |
Scholar Rock (SRRK) | 10/1/2023 - 11/30/2023 | 78.58% |
Harmony Gold Mining (HMY) | 10/1/2023 - 11/30/2023 | 76.34% |
Spirit Aerosystems (SPR) | 10/1/2023 - 11/30/2023 | 71.06% |
Telecom Argentina SA ADR (TEO) | 10/1/2023 - 11/30/2023 | 70.66% |
Foot Locker (FL) | 10/1/2023 - 11/30/2023 | 58.23% |
New Gold (NGD) | 10/1/2023 - 11/30/2023 | 56.67% |
Oscar Health (OSCR) | 10/1/2023 - 11/30/2023 | 54.55% |
Lemonade (LMND) | 10/1/2023 - 11/30/2023 | 52.99% |
TG Therapeutics (TGTX) | 10/1/2023 - 11/30/2023 | 51.6% |
Impinj (PI) | 10/1/2023 - 11/30/2023 | 51.57% |
Eldorado Gold (EGO) | 10/1/2023 - 11/30/2023 | 50.4% |
Kymera Therapeutics (KYMR) | 10/1/2023 - 11/30/2023 | 49.89% |
CleanSpark (CLSK) | 10/1/2023 - 11/30/2023 | 49.77% |
RLX Technology (RLX) | 10/1/2023 - 11/30/2023 | 48.66% |
Crispr Therapeutics (CRSP) | 10/1/2023 - 11/30/2023 | 47.47% |
StoneCo (STNE) | 10/1/2023 - 11/30/2023 | 46.89% |
F&G Annuities & Life (FG) | 10/1/2023 - 11/30/2023 | 46.69% |
Triumph (TGI) | 10/1/2023 - 11/30/2023 | 46.47% |
Arcellx (ACLX) | 10/1/2023 - 11/30/2023 | 46.12% |
Rhythm Pharmaceuticals (RYTM) | 10/1/2023 - 11/30/2023 | 45.86% |
Fortuna Silver Mines (FSM) | 10/1/2023 - 11/30/2023 | 45.52% |
Companhia Siderurgica Nacional ADR (SID) | 10/1/2023 - 11/30/2023 | 45.49% |
BRF SA ADR (BRFS) | 10/1/2023 - 11/30/2023 | 43.84% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
